BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11732106)

  • 1. [Insulin analogs: structure, properties and therapeutic indications. Part 1: rapid-acting insulin analogs].
    Rosak C
    Internist (Berl); 2001 Nov; 42(11):1523-35. PubMed ID: 11732106
    [No Abstract]   [Full Text] [Related]  

  • 2. The insulin analog glargine during an unplanned pregnancy.
    Cechurová D; Lacigová S; Jankovec Z; Haladová I; Zourek M; Krcma M; Rusavý Z; Turek J
    Wien Klin Wochenschr; 2006 Oct; 118(19-20):619-20. PubMed ID: 17136338
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacokinetics and pharmacodynamics of insulin aspart.
    Lindholm A; Jacobsen LV
    Clin Pharmacokinet; 2001; 40(9):641-59. PubMed ID: 11605714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs.
    Lindström T; Hedman CA; Arnqvist HJ
    Diabetes Care; 2002 Jun; 25(6):1049-54. PubMed ID: 12032113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of insulin glargine during pregnancy in a type 1 diabetic woman.
    Devlin JT; Hothersall L; Wilkis JL
    Diabetes Care; 2002 Jun; 25(6):1095-6. PubMed ID: 12032121
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
    Kitzmiller JL; Main E; Ward B; Theiss T; Peterson DL
    Diabetes Care; 1999 May; 22(5):874-6. PubMed ID: 10332713
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's Disease.
    Dolci M; Mori M; Baccetti F
    Diabetes Care; 2005 Aug; 28(8):2084-5. PubMed ID: 16043769
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin lispro: a useful advance in insulin therapy.
    Heller S
    Expert Opin Pharmacother; 2003 Aug; 4(8):1407-16. PubMed ID: 12877647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.
    Hermansen K; Colombo M; Storgaard H; ØStergaard A; Kølendorf K; Madsbad S
    Diabetes Care; 2002 May; 25(5):883-8. PubMed ID: 11978685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin analogues.
    Marks J
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):8-12. PubMed ID: 19667599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects.
    Homko C; Deluzio A; Jimenez C; Kolaczynski JW; Boden G
    Diabetes Care; 2003 Jul; 26(7):2027-31. PubMed ID: 12832307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
    Wilde MI; McTavish D
    Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Can insulin humalog be given during pregnancy?].
    Scherbaum WA
    Dtsch Med Wochenschr; 2003 May; 128(21):1190. PubMed ID: 12761695
    [No Abstract]   [Full Text] [Related]  

  • 16. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin aspart: a review.
    Owens D; Vora J
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin lispro (Humalog), a novel fast-acting insulin analogue for the treatment of diabetes mellitus: overview of pharmacological and clinical data.
    Hermans MP; Nobels FR; De Leeuw I
    Acta Clin Belg; 1999 Oct; 54(5):233-40. PubMed ID: 10555380
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences.
    Home PD
    Diabetes Obes Metab; 2012 Sep; 14(9):780-8. PubMed ID: 22321739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.